SCHEMBL30101062

SCHEMBL30101062

N#Cc1cc(N)ccc1-c1ccc(N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 3/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.46
STS P08842 1/20 0.44
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
ESR2 Q92731 1/20 0.41
CYP3A4 P08684 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
TP53 P04637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22780766 0.88 KDM4E (0.53) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL30533023 0.88 KDM4E (0.53) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL8866245 0.87 KDM4E (0.54) KDM4EALDH1A1USP2LMNASTS
SCHEMBL2638947 0.87 KDM4E (0.55) KDM4EALDH1A1USP2LMNASTS
SCHEMBL9019577 0.86 KDM4E (0.44) KDM4EALDH1A1USP2LMNASTS
SCHEMBL21715808 0.86 KDM4E (0.44) KDM4EALDH1A1USP2LMNASTS
SCHEMBL8111393 0.85 KDM4E (0.45) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL23915974 0.84 KIF11 (0.52) KDM4EALDH1A1USP2LMNAMAPT
SCHEMBL21136501 0.84 ALDH1A1 (0.56) KDM4EALDH1A1USP2STSMAPT
SCHEMBL3898071 0.81 ALOX5AP (0.56) ALDH1A1STSMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253326-A1 NLRP3 INFLAMMASOME INHIBITOR AND APPLICATION THEREOF 药捷安康(南京)科技股份有限公司 2022-12-08 WO disclosed